Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Isthmin-1 Level as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

NCT07374367 is registered in ClinicalTrials.gov with Amera Imam Abdel - Ghany Ahmed as lead sponsor.

NCT NCT07374367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Isthmin-1 Level as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings
Lead sponsor
Amera Imam Abdel - Ghany Ahmed
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
December 1, 2027
Enrollment
66 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

disease activity